# China Approves More AI Medical Devices, Expands Into Treatment > Source: > Published: 2026-07-07 18:01:44+00:00 China's **NMPA** has approved several **Class III AI medical-device** registrations in 2026, moving the category beyond diagnostic support into pathology, endoscopy and surgical-navigation use cases, according to ECNS. The near-term implication is operational rather than speculative: AI vendors entering treatment-adjacent workflows face device-grade review, hospital procurement checks and post-market monitoring expectations, not just software pilots. For practitioners, the useful signal is that **clinical AI** in China is being packaged into regulated equipment and multimodal systems that combine imaging, electronic records and procedural data. The source does not name every product or provide a full approval count, so this should be read as a regulatory and deployment trend, not a product-by-product market map.